Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement ...

While genetic testing rates for advanced ovarian cancer have increased, gaps in physician understanding and confidence in interpreting results may limit optimal biomarker-driven treatment and patient ...

A new study shows how an anticancer drug triggers an 'outside in' signal that gets it sucked into a cancer cell. The work reveals a new signaling mechanism that could be exploited for delivering other ...

A new study shows how an anticancer drug triggers an "outside in" signal that gets it sucked into a cancer cell. The work, published Jan. 29 in Nature Communications, reveals a new signaling mechanism ...

Scientists have developed retriever, a computational tool that extracts disease-specific drug response signatures to predict the best combinations for cancer treatment.

The ovarian reserve is the number of healthy eggs ... College of Public Health and program coordinator of the Fire Fighter Cancer Cohort Study's Women Firefighter Study. The paper "Evaluating ...

Their work showcases the combined power of bioinformatics, IHC, and multiplex immunofluorescence (MIF) for characterizing TLS and identifying clinically relevant markers. 1.3 TLS in non-small cell ...

We have yet to find the cure for cancer, but there are ways to treat the disease and mitigate your risk of dying from it - like these popular medications.

The ChemoFx® treatment selection marker ... cancer cases are diagnosed each year, the most frequent of which are endometrial, cervical and ovarian. “Of the approximately 150,000 live cell ...

diabetes or breast cancer patients on tamoxifen, would certainly benefit from the advent of a reliable serum-marker panel to aid early diagnosis. Noninvasive means for detecting EC may improve ...

Mowbray stepped down at Birmingham City in February last year for medical treatment but has received the all-clear from medical ... Reflecting on his bowel cancer diagnosis last November, Mowbray ...

The ChemoFx® treatment selection marker and tumor ... 250,000 gynecologic cancer cases are diagnosed each year, the most frequent of which are endometrial, cervical and ovarian. "Of the approximately ...